16:50 EDT NLS Pharmaceutics (NLSP) files to sell 5M common shares for holders
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NLSP:
- NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation
- NLS Pharmaceutics and Kadimastem Secure SEC Approval for Merger
- NLS Pharmaceutics and Kadimastem Secure Hong Kong Patent for Diabetes Therapy
- NLS Pharmaceutics and Kadimastem granted patent in Hong Kong for diabetes
- NLS Pharmaceutics Extends Merger Agreement with Kadimastem